+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor Drug"

From
From
From
From
From
From
From
From
From
From
From
From
Myc Proto Oncogene Protein - Pipeline Review, H2 2020 - Product Thumbnail Image

Myc Proto Oncogene Protein - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 56 Pages
  • Global
From
From
Neuroendocrine Tumors - Pipeline Review, H1 2020 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 795 Pages
  • Global
From
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2020 - Product Thumbnail Image

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 627 Pages
  • Global
From
From
T Cell Specific Surface Glycoprotein CD28 - Pipeline Review, H2 2019 - Product Thumbnail Image

T Cell Specific Surface Glycoprotein CD28 - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 73 Pages
  • Global
From
Loading Indicator

The Tumor Drug market is a subset of the Oncology Drugs market, which focuses on the development and sale of drugs used to treat cancer. These drugs are used to target and destroy cancer cells, reduce the size of tumors, and reduce the spread of cancer. Tumor drugs are typically divided into two categories: cytotoxic drugs, which kill cancer cells, and targeted therapies, which target specific molecules involved in cancer growth. These drugs are often used in combination with other treatments, such as radiation and surgery, to maximize the effectiveness of treatment. The Tumor Drug market is highly competitive, with many companies developing and selling drugs to treat cancer. Some of the major players in the market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. Other companies, such as AstraZeneca, Eli Lilly, and Amgen, are also active in the market. Show Less Read more